Skip to content

The efficacy and safety of weissella cibaria CMU on halitosis

A 8 week, randomized, double-blind, placebo-controllled clinical trlial for the evaluation of the efficacy and safety of weissella cibaria CMU on halitosis.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CRIS
Registry ID
KCT0003301
Enrollment
60
Registered
2018-10-26
Start date
2017-09-11
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : The test group was Weissella cibaria CMU (1.0 × 10 8 CFU / pack), and the control group is maltodextrin. One 1000 mg each is taken once a day in the mouth before sleeping and tak

Sponsors

Dankook University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Male and female aged 20 to over 70 2) A person with a score of 2 or more in the bad taste sensory evaluation (OLT) and a VSC concentration (H2S, CH3SH, (CH3) 2S) of 1.5ng or more 3) The person who agrees to participate in this test and who has voluntarily signed the written agreement (or legal representative)

Exclusion criteria

Exclusion criteria: 1) Those who are currently being treated or have a history of systemic disease (liver disease, renal disease, Sjogren's syndrome, rheumatic disease) that may cause bad breath (however, taking into consideration the condition of the subject, 2) Persons with severe dental disease (periodontal disease, dental caries, dry mouth) (dental caries in the dental caries test may be included in the test, except when more than one dental caries) 3) Those with uncontrolled hypertension (160 / 100mmHg or higher, after 5 minutes of test subjects ) 4) diabetic patients taking fasting blood glucose levels greater than 126 mg / dl, randomized blood glucose levels greater than 200 mg / dl, or taking oral hypoglycemic agents or insulin 5) AST (GOT) or ALT (GPT) blood pressure is three times higher than the normal upper limit of the institution 6) creatinine whose plasma level is more than twice the upper limit of normal level 7) Those taking antibiotics within 2 weeks before screening 8) Smokers 9) Those who complain of severe gastrointestinal symptoms such as heartburn and indigestion 10) Screening criteria Probiotic health functional foods within one week and those who consume fermented milk continuously (more than 4 times a week) 11) Those who are pregnant, breastfeeding, or who have a pregnancy plan during the study period 12) Applicable to human body Any person who is sensitive or allergic to food related food 13) Those who intend to participate in other tests during this human body application test. 14) Those who participated in another human body test within 4 weeks 15) A person who is deemed by the tester to be unsuitable for this human body test

Design outcomes

Primary

MeasureTime frame
Volatile sulfur compound concentrationby Oralchroma

Secondary

MeasureTime frame
Organoleptic halitosis check;tongue plaque;simplified oral hygiene index;simplified oral hygiene index;gingival index

Countries

Korea, Republic of

Contacts

Public ContactEUNSIM KIM

Dankook University Dental Hostipal

plusoten@naver.com+82-41-550-1953

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026